![](/img/cover-not-exists.png)
Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)
Durmus, Selvi, Sparidans, Rolf W., van Esch, Anita, Wagenaar, Els, Beijnen, Jos H., Schinkel, Alfred H.Volume:
32
Language:
english
Journal:
Pharmaceutical Research
DOI:
10.1007/s11095-014-1442-z
Date:
January, 2015
File:
PDF, 903 KB
english, 2015